Dealert Deals Groupe NOBILEA

Océan Participations, YOTTA Capital Partners, Ouest Croissance, Bpifrance, management Groupe NOBILEA

Buyout France Alternative Medicine Other / Unspecified
Deal summary

Information on the target

Océan Participations has recently increased its investment in the healthcare sector by acquiring a stake in Groupe NOBILEA, which includes Laboratoires Herbolistique and Vallée Nature. Established in Chanverrie, Vendée, Laboratoires Herbolistique specializes in the production and commercialization of natural dietary supplements. With a commitment to quality and innovation, the company aims to become a leading player in the alternative medicine market.

This strategic move follows Océan Participations' previous partnership with Laboratoires Herbolistique, which began in 2021. The continued collaboration underscores a shared vision for growth and development, supported by a consortium of investors including YOTTA Capital Partners, Ouest Croissance, and Bpifrance.

Industry overview in the target’s specific country

The alternative medicine industry in France has seen significant growth in recent years, driven by increasing consumer demand for natural and holistic health solutions. This trend is largely influenced by a growing awareness of the potential side effects of conventional pharmaceuticals and a desire for more personalized healthcare options. As a result, alternative medicine practices, including herbal remedies, acupuncture, and dietary supplements, have gained traction among the French population.

France's regulatory framework for alternative medicine is evolving, with the government recognizing the importance of integrating complementary therapies into the broader healthcare system. This shift is reflected in the increasing number of practitioners and the establishment of professional associations that advocate for the legitimacy and safety of alternative treatments. The French market is characterized by a diverse range of products, from herbal supplements to homeopathic remedies, catering to a wide array of health concerns.

Moreover, the COVID-19 pandemic has accelerated the shift towards preventive health measures, further propelling the alternative medicine sector. Consumers are increasingly seeking ways to enhance their immune systems and overall well-being, leading to a surge in demand for natural health products. This trend presents a unique opportunity for companies like Laboratoires Herbolistique to expand their offerings and capture a larger market share.

As the alternative medicine industry continues to mature, it is expected that innovation and research will play a crucial role in shaping its future. Companie…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗